Broad Institute

MAY 14, 2024

His T7 expression technology can be used to make large quantities of nearly any RNA or protein and has been for decades, and continues to be, a mainstay of biomedical research and pharmaceutical production. In 2020, scientists used the T7 platform to produce enough mRNA for COVID-19 vaccines to vaccinate millions of people in the U.S.

RNA 84

RNA Production Molecular Biology Laboratories 84

Codon

MAY 30, 2023

Read *An engineered influenza virus to deliver antigens for lung cancer vaccination. Read Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia. Read | News Improving the soluble expression of difficult-to-express proteins in prokaryotic expression system via protein engineering and synthetic biology strategies.

DNA 52

DNA RNA Engineering Vaccine 52

Codon

MAY 30, 2023

Read *An engineered influenza virus to deliver antigens for lung cancer vaccination. Read Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia. Read | News Improving the soluble expression of difficult-to-express proteins in prokaryotic expression system via protein engineering and synthetic biology strategies.

DNA 52

DNA RNA Engineering Vaccine 52

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2015). FEMS Yeast Research (2015). Link Methods for the directed evolution of proteins , by Packer M.S. & Nature Reviews Genetics (2015). Link Protein Structure Prediction & Design →Advances in protein structure prediction and design , by Kuhlman B. &

DNA 52

DNA Cell Biology Engineering Molecular Biology 52